Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Shirai

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Anticancer Research|July 24, 2010
Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinomaPavel V Korita, Toshifumi Wakai, Yoichi Ajioka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2009
[Pharmacokinetic monitoring of 5-fluorouracil may improve the clinical benefit with an individualized regimen-a case report]Katsuki Muneoka, Yoshio Shirai, Masataka Sasaki, et al.
International Journal of Clinical and Experimental Pathology|June 7, 2012
Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasisToshifumi Wakai, Yoshio Shirai, Jun Sakata, et al.
Journal of Pediatric Surgery|March 7, 2006
Treatment of a case with right-sided diaphragmatic hernia associated with an abnormal vessel communication between a herniated liver and the right lungShinji Tanaka, Masayuki Kubota, Minoru Yagi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 18, 2008
[Team-based medical care can improve tailor made chemotherapy for colorectal cancer]Katsuki Muneoka, Yoshio Shirai, Masataka Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2010
[Effect of pylorus-preserving pancreaticoduodenectomy on serum levels of 5-fluorouracil during S-1 treatment for pancreaticobiliary malignancy]Katsuki Muneoka, Yoshio Shirai, Masataka Sasaki, et al.
Cancer|December 2, 2009
Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinomaMasayuki Nagahashi, Yoshio Shirai, Toshifumi Wakai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2017
[The Changes in the Neutrophil-to-Lymphocyte Ratio Can Predict the Timing of Chemotherapeutic Regimen Alteration in Patients with Metastatic Colorectal Cancer]Katsuki Muneoka, Yoshio Shirai, Masataka Sasaki, et al.
Hepato-Gastroenterology|March 13, 2003
Postoperative management for donor safety in living related donor liver transplantationYoshinobu Sato, Isao Kurosaki, Satoshi Yamamoto, et al.
International Journal of Clinical and Experimental Pathology|May 18, 2011
Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinomaToshifumi Wakai, Yoshio Shirai, Jun Sakata, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Anticancer Research|July 24, 2010
Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinomaPavel V Korita, Toshifumi Wakai, Yoichi Ajioka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2009
[Pharmacokinetic monitoring of 5-fluorouracil may improve the clinical benefit with an individualized regimen-a case report]Katsuki Muneoka, Yoshio Shirai, Masataka Sasaki, et al.
International Journal of Clinical and Experimental Pathology|June 7, 2012
Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasisToshifumi Wakai, Yoshio Shirai, Jun Sakata, et al.
Journal of Pediatric Surgery|March 7, 2006
Treatment of a case with right-sided diaphragmatic hernia associated with an abnormal vessel communication between a herniated liver and the right lungShinji Tanaka, Masayuki Kubota, Minoru Yagi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 18, 2008
[Team-based medical care can improve tailor made chemotherapy for colorectal cancer]Katsuki Muneoka, Yoshio Shirai, Masataka Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2010
[Effect of pylorus-preserving pancreaticoduodenectomy on serum levels of 5-fluorouracil during S-1 treatment for pancreaticobiliary malignancy]Katsuki Muneoka, Yoshio Shirai, Masataka Sasaki, et al.
Cancer|December 2, 2009
Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinomaMasayuki Nagahashi, Yoshio Shirai, Toshifumi Wakai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2017
[The Changes in the Neutrophil-to-Lymphocyte Ratio Can Predict the Timing of Chemotherapeutic Regimen Alteration in Patients with Metastatic Colorectal Cancer]Katsuki Muneoka, Yoshio Shirai, Masataka Sasaki, et al.
Hepato-Gastroenterology|March 13, 2003
Postoperative management for donor safety in living related donor liver transplantationYoshinobu Sato, Isao Kurosaki, Satoshi Yamamoto, et al.
International Journal of Clinical and Experimental Pathology|May 18, 2011
Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinomaToshifumi Wakai, Yoshio Shirai, Jun Sakata, et al.
Pageof 10